Publications by authors named "K Beyfuss"

Article Synopsis
  • The study investigates the impact of tranexamic acid (TXA) on the need for red blood cell transfusions (RBCT) during hepatectomy for colorectal liver metastases (CRLM).
  • TXA was given to 146 out of 433 patients, and its use was linked to a significant 41% reduction in the likelihood of requiring RBCT within 30 days post-surgery.
  • The use of TXA did not show increased risk for major complications or mortality, suggesting it could enhance patient outcomes and optimize healthcare resources.
View Article and Find Full Text PDF

Background: Although pancreatic adenocarcinoma (PA) surgery performed by high-volume (HV) providers yields better outcomes, volume-outcome relationships are unknown for medical oncologists. This study examined variation in practice and outcomes in noncurative management of PA based on medical oncology provider volume.

Methods: This population-based cohort study linked administrative healthcare datasets and included nonresected PA from 2005 through 2016.

View Article and Find Full Text PDF

Background: How to best support patients with neuroendocrine tumors (NETs) remains unclear. Improving quality of care requires an understanding of symptom trajectories. Objective validated assessments of symptoms burden over the course of disease are lacking.

View Article and Find Full Text PDF

Background: Given a slow course of disease, end-of-life issues are understudied in neuroendocrine tumors (NETs). To date, there are no data regarding symptoms at the end of life. This study examined symptom trajectories and factors associated with high symptom burden in NETs at the end of life.

View Article and Find Full Text PDF

Background: Although advancements in systemic therapy have improved the outlook for pancreatic adenocarcinoma, it is not known if patients get access to these therapies. We aimed to examine the patterns and factors associated with access to specialized cancer consultations and subsequent receipt of cancer-directed therapy for patients with non-curative pancreatic adenocarcinoma.

Methods: We conducted a population-based analysis of noncurative pancreatic adenocarcinoma diagnosed over 2005-2016 in Ontario by linking administrative health care data sets.

View Article and Find Full Text PDF